The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Cited by (1,000)

Items 201–300 of 1,000

  1. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
    Wenxuan Du, Olivier Elemento · 2014 · Oncogene
  2. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Carolyn S. Grove, George S. Vassiliou · 2014 · Disease Models & Mechanisms
  3. Genetically engineered mouse models of pancreatic adenocarcinoma
    Carmen E. Guerra, Mariano Barbacid · 2013 · Molecular Oncology
  4. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
    David N. Brown, Dominiek Smeets, Borbála Székely, Denis Larsimont, Attila Marcell Szász, Pierre-Yves Adnet, Françoise Rothé, Ghizlane Rouas, Zsófia Nagy, Zsófia Faragó et al. · 2017 · Nature Communications
  5. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors
    Lihua Luo, Chunqi Zhu, Hang Yin, Mengshi Jiang, Junlei Zhang, Bing Qin, Zhenyu Luo, Xiaoling Yuan, Jie Yang, Wei Li et al. · 2018 · ACS Nano
  6. What does physics have to do with cancer?
    Franziska Michor, Jan Liphardt, Mauro Ferrari B, Jonathan Widom · 2011 · Nature reviews. Cancer
  7. Genome-Scale Sequence Disruption Following Biolistic Transformation in Rice and Maize
    Jianing Liu, Natalie J. Nannas, Fangfang Fu, Jinghua Shi, Brooke Aspinwall, Wayne Allen Parrott, R. Kelly Dawe · 2019 · The Plant Cell
  8. From human genome to cancer genome: The first decade
    David A. Wheeler, Linghua Wang · 2013 · Genome Research
  9. An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
    Xue, Yaohua, Martelotto, Luciano, Baslan, Timour, Vides, Alberto, Solomon, Martha, Mai, Trang Thi, Chaudhary, Neelam, Riely, Greg J, Li, Bob T, Scott, Kerry et al. · 2017 · Nature Medicine
  10. The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations
    Francesca Menghi, Floris P Barthel, Vinod Kumar Yadav, Ming Tang, Bo Ji, Zhonghui Tang, Gregory W. Carter, Yijun Ruan, Ralph Scully, Roel G.W. Verhaak et al. · 2018 · Cancer Cell
  11. What We Have Learned About Pancreatic Cancer From Mouse Models
    Pedro Antonio Pérez-Mancera, Carmen E. Guerra, Mariano Barbacid, David A. Tuveson · 2012 · Gastroenterology
  12. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data
    Andrew J. L. Roth, Jiarui Ding, Ryan D. Morin, Anamaria Crisan, Gavin Ha, Ryan Giuliany, Ali Bashashati, Martin Hirst, Gulisa Turashvili, Arusha Oloumi et al. · 2012 · Bioinformatics
  13. Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
    Heidrun Gevensleben, Isaac García-Murillas, Monika Graeser, Gaia Schiavon, Peter Osin, Marina Parton, Ian E. Smith, Alan Ashworth, Nicholas C. Turner · 2013 · Clinical Cancer Research
  14. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
    Richard L. Sleightholm, Beth K. Neilsen, Jing Li, Maria M. Steele, Rakesh K. Singh, Michael Anthony Hollingsworth, David Oupický · 2017 · Pharmacology & Therapeutics
  15. Reconstructing metastatic seeding patterns of human cancers
    Johannes G. Reiter, Alvin P. Makohon-Moore, Jeffrey M. Gerold, Ivana Božić, Krishnendu Chatterjee, Christine A. Iacobuzio–Donahue, Bert Vogelstein, Martin A. Nowak · 2017 · Nature Communications
  16. Phylogenetic Quantification of Intra-tumour Heterogeneity
    Roland F. Schwarz, Anne C. Trinh, Botond Sipos, James D. Brenton, Nick Goldman, Florian M. Markowetz · 2014 · PLoS Computational Biology
  17. Cancer research: past, present and future
    Ya Cao, Ronald Anthony DePinho, Matthias Ernst, Karen H. Vousden · 2011 · Nature reviews. Cancer
  18. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
    Lucy R. Yates, Joan Seoane, Christophe Le Tourneau, Lillian L. Siu, Richard Marais, Stefan Michiels, Jean‐Charles Soria, Peter J. Campbell, Nicola Normanno, Aldo Scarpa et al. · 2017 · Annals of Oncology
  19. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
    Roman Maresch, Sebastian Mueller, Christian Veltkamp, Rupert Öllinger, Mathias Friedrich, Irina Heid, Katja Steiger, Julia Weber, Thomas Engleitner, Maxim Barenboim et al. · 2016 · Nature Communications
  20. Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule
    Chiara Marchetti, Katherine G. Zyner, Stephan A. Ohnmacht, Mathew P. Robson, Shozeb M Haider, Jennifer P. Morton, Giovanni Marsico, Tam D. Vo, Sarah Laughlin, Ahmed A. Ahmed et al. · 2018 · Journal of Medicinal Chemistry
  21. The Role of Telomere Biology in Cancer
    Xu, Lifeng, Li, Shang, Stohr, Bradley A. · 2013 · Annual Review of Pathology: Mechanisms of Disease
  22. Evolutionary medicine: its scope, interest and potential
    Stephen C. Stearns · 2012 · Proceedings of the Royal Society B Biological Sciences
  23. Genetic insights into the morass of metastatic heterogeneity
    Kent W. Hunter, Ruhul Amin, Sarah K. Deasy, Ngoc‐Han Ha, Lalage M. Wakefield · 2018 · Nature reviews. Cancer
  24. Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy
    Davendra P. S. Sohal, Richard Matthew Walsh, Ramesh K. Ramanathan, Alok A. Khorana · 2014 · JNCI Journal of the National Cancer Institute
  25. The causes of replication stress and their consequences on genome stability and cell fate
    Indiana Magdalou, Bernard S. López, Philippe Pasero, Sarah Lambert · 2014 · Seminars in Cell and Developmental Biology
  26. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis
    Ruoyu Miao, Haitao Luo, Huandi Zhou, Guangbing Li, Dechao Bu, Xiaobo Yang, Xue Zhao, Haohai Zhang, Song Liu, Ying Zhong et al. · 2014 · Journal of Hepatology
  27. Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development
    Stephan B. Dreyer, David Kuang-Fu Chang, Peter J. Bailey, Andrew Victor Biankin · 2017 · Clinical Cancer Research
  28. Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
    Morrow, James J, Bayles, Ian, Funnell, Alister P W, Miller, Tyler E, Saiakhova, Alina, Lizardo, Michael M, Bartels, Cynthia F, Kapteijn, Maaike Y, Hung, Stevephen, Mendoza, Arnulfo et al. · 2018 · Nature Medicine
  29. Mechanisms of telomere loss and their consequences for chromosome instability
    Keiko Muraki, Kristine C. Nyhan, Limei Han, John P. Murnane · 2012 · Frontiers in Oncology
  30. Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis
    Nuh N. Rahbari, Ulrich Bork, Edith Motschall, Kristian Thorlund, Markus Wolfgang Büchler, Moritz Koch, Jürgen Weitz · 2011 · Journal of Clinical Oncology
  31. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics
    Rama R. Gullapalli, Ketaki Desai, Lucas Santana‐Santos, Jeffrey A. Kant, Michael John Becich · 2012 · Journal of Pathology Informatics
  32. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project
    Christine A. Iacobuzio–Donahue · 2011 · Gut
  33. Actin-bundling proteins in cancer progression at a glance
    Richard P. Stevenson, Douwe M. Veltman, Laura M. Machesky · 2012 · Journal of Cell Science
  34. Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment
    Joost S.P. Vermaat, Isaäc J. Nijman, Marco J. Koudijs, Frank L. Gerritse, Stefan J. Scherer, Michal Mokrý, Wijnand M. Roessingh, Nico R. Lansu, Ewart de Bruijn, Richard van Hillegersberg et al. · 2011 · Clinical Cancer Research
  35. A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
    Ferrari, Anthony, Vincent-Salomon, Anne, Pivot, Xavier, Sertier, Anne-Sophie, Thomas, Emilie, Tonon, Laurie, Boyault, Sandrine, Mulugeta, Eskeatnaf, Treilleux, Isabelle, MacGrogan, Gaëtan et al. · 2016 · Nature Communications
  36. Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB – NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome
    Yoshitsugu Mitani, Pulivarthi H. Rao, P. Andrew Futreal, Dianna B. Roberts, Philip J. Stephens, Yi-Jue Zhao, Li Zhang, Mutsumi Mitani, Randal S. Weber, Scott Michael Lippman et al. · 2011 · Clinical Cancer Research
  37. Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
    Alison Chan, Ioannis Prassas, Apostolos Dimitromanolakis, Randall E. Brand, Stefano Serra, Eleftherios P. Diamandis, Ivan M. Blasutig · 2014 · Clinical Cancer Research
  38. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
    Patricia Dauer, Alice Nomura, Ashok Saluja, Sulagna Banerjee · 2016 · Pancreatology
  39. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability
    Yotam Drier, Michael S. Lawrence, Scott L. Carter, Chip Stewart, Stacey Gabriel, Eric S. Lander, Matthew M. Meyerson, Rameen Beroukhim, Gad A. Getz · 2012 · Genome Research
  40. A cell‐based model system links chromothripsis with hyperploidy
    Balca R. Mardin, Alexandros P. Drainas, Sebastian M. Waszak, Joachim Weischenfeldt, Mayumi Isokane, Adrian M. Stütz, Benjamin Raeder, Theocharis Efthymiopoulos, Christopher Buccitelli, Maia Segura‐Wang et al. · 2015 · Molecular Systems Biology
  41. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity
    Fei Yao, Jaya P. Kausalya, Yee Yen Sia, Audrey S.M. Teo, Wah Heng Lee, Alicia Ghia Min Ong, Zhenshui Zhang, Joanna Hui Juan Tan, Guoliang Li, Denis Bertrand et al. · 2015 · Cell Reports
  42. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
    Eun-Kyung Kim, Mingyeong Jang, Min-Jeong Song, Dong‐Woo Kim, Yosup Kim, Ho Hee Jang · 2019 · Antioxidants
  43. Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance
    Anup Kumar Singh, Rakesh Kumar Arya, Shrankhla Maheshwari, Akhilesh Singh, Sanjeev Meena, Priyanka Pandey, Olivier Dormond, Dipak B. Datta · 2014 · International Journal of Cancer
  44. Using tumour phylogenetics to identify the roots of metastasis in humans
    Kamila Naxerova, Rakesh K. Jain · 2015 · Nature Reviews Clinical Oncology
  45. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
    Caixia Cheng, Yong Zhou, Hongyi Li, Teng Xiong, Shuai Cheng Li, Yanghui Bi, Pengzhou Kong, Fang Wang, Heyang Cui, Yaoping Li et al. · 2016 · The American Journal of Human Genetics
  46. Evolution of cellular morpho-phenotypes in cancer metastasis.
    Wu, Pei-Hsun, Phillip, Jude M., Khatau, Shyam B., Chen, Wei-Chiang, Stirman, Jeffrey, Rosseel, Sophie, Tschudi, Katherine, Van Patten, Joshua, Wong, Michael, Gupta, Sonal et al. · 2015 · Scientific Reports
  47. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
    Syed Haider, Jun Wang, A. Nagano, Ami Desai, Prabhu Arumugam, Laurent Dumartin, Jude Fitzgibbon, Thorsten Hagemann, John F. Marshall, Hemant Mahendrakumar Kocher et al. · 2014 · Genome Medicine
  48. Metastasis Suppressor Genes
    Douglas R. Hurst, Danny R. Welch · 2011 · International review of cytology
  49. Hallmarks of cancer: of all cancer cells, all the time?
    Sébastien L. Floor, Jacques E. Dumont, Carine Maenhaut, Eric Raspé · 2012 · Trends in Molecular Medicine
  50. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
    Àlvaro Aytés, Antonina Mitrofanova, Carolyn Waugh Kinkade, Céline Lefèbvre, Ming Lei, Vanessa Phelan, Carl Lekaye, Jason A. Koutcher, Robert D. Cardiff, Andrea Califano et al. · 2013 · Proceedings of the National Academy of Sciences
  51. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
    Gloria Vittone Echeverria, Emily Powell, Sahil Seth, Zhongqi Ge, Alessandro Carugo, Christopher Aaron Bristow, Michael D. Peoples, Frederick Scott Robinson, Huan Qiu, Jiansu Shao et al. · 2018 · Nature Communications
  52. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
    Jake June-Koo Lee, Yoon‐La Choi, Mijung Kwon, Peter J. Park · 2016 · Annual Review of Pathology Mechanisms of Disease
  53. Early phase clinical trials to identify optimal dosing and safety
    Natalie Cook, Aaron Richard Hansen, Lillian L. Siu, Albiruni R. Abdul Razak · 2014 · Molecular Oncology
  54. The Rise of Radiomics and Implications for Oncologic Management
    Vivek Verma, Charles B. Simone, Sunil Krishnan, Steven Hsesheng Lin, Jinzhong Yang, Stephen M. Hahn · 2017 · JNCI Journal of the National Cancer Institute
  55. Cancer biomarker discovery: Current status and future perspectives
    Katrin Mäbert, Monica Cojoc, Claudia Peitzsch, Ina Kurth, Serhiy Souchelnytskyi, Anna Dubrovska · 2014 · International Journal of Radiation Biology
  56. Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
    Singh, Mallika, Murriel, Christopher L., Johnson, Leisa · 2012 · Cancer Research
  57. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells
    Hu, Chun-Mei, Tien, Sui-Chih, Hsieh, Ping-Kun, Jeng, Yung-Ming, Chang, Ming-Chu, Chang, Yu-Ting, Chen, Yi-Ju, Chen, Yu-Ju, Lee, Eva Y.-H.P., Lee, Wen-Hwa · 2019 · Cell Metabolism
  58. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
    Bianca Mostert, Yuqiu Jiang, Anieta M. Sieuwerts, Haiying Wang, Joan Bolt‐de Vries, Katharina Biermann, Jaco Kraan, Zarina S. Lalmahomed, Anne van Galen, Vanja de Weerd et al. · 2012 · International Journal of Cancer
  59. Carcinoma-associated fibroblasts provide operational flexibility in metastasis
    Olivier De Wever, Mieke Van Bockstal, Marc Mareel, An Hendrix, Marc Bracke · 2014 · Seminars in Cancer Biology
  60. Mutational landscape of yeast mutator strains
    Serero, Alexandre, Jubin, Claire, Loeillet, Sophie, Legoix-Né, Patricia, Nicolas, Alain G. · 2014 · Proceedings of the National Academy of Sciences
  61. TrAp: a tree approach for fingerprinting subclonal tumor composition
    Francesco Strino, Fabio Parisi, Mariann Micsinai, Yuval Kluger · 2013 · Nucleic Acids Research
  62. Metabolic reprogramming of the tumor
    Leonardo M. R. Ferreira, Aline Hébrant, J.E. Dumont · 2012 · Oncogene
  63. Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas
    Barry S. Taylor, Penelope L. DeCarolis, Christina Vadala Angeles, Fabienne A. Brenet, Nikolaus D. Schultz, Cristina R. Antonescu, Joseph Michael Scandura, Chris Sander, Agnes J. Viale, Nicholas D. Socci et al. · 2011 · Cancer Discovery
  64. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
    Elvira Pelosi, Germana Castelli, Ugo Testa · 2017 · Biomedicines
  65. Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
    Yannick Delpu, Naima Hanoun, Hubert Lulka, Flavie Sicard, Janick Sèlves, Louis Buscail, Jérôme Torrisani, Pierre Cordelier · 2011 · Current Genomics
  66. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
    Diego M. Marzese, Hajime Hirose, Dave S.�B. Hoon · 2013 · Expert Review of Molecular Diagnostics
  67. Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
    Hongsheng Wang, Qiuxiang Ou, Delan Li, Tao Qin, Hua Bao, Xue Hou, Kaicheng Wang, Fang Wang, Qianqian Deng, Liang Jianzhong et al. · 2019 · Cancer
  68. ERα-associated translocations underlie oncogene amplifications in breast cancer
    Jake June-Koo Lee, Youngsook Lucy Jung, Taek-Chin Cheong, Jose Espejo Valle-Inclán, Chong Chu, D. Gulhan, Viktor Ljungström, Hu Jin, Vinay Viswanadham, Emma V. Watson et al. · 2023 · Nature
  69. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?
    Rooman, Ilse, Real, Francisco X · 2012 · Gut
  70. Drosophila cancer models
    Vivek Ashok Rudrapatna, Ross Leigh Cagan, Tirtha K. Das · 2011 · Developmental Dynamics
  71. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications
    Samuel Peña‐Llopis, James Brugarolas · 2013 · Nature Protocols
  72. Genome profiling of pancreatic adenocarcinoma
    Birnbaum, David J., Adélaïde, José, Mamessier, Emilie, Finetti, Pascal, Lagarde, Arnaud, Monges, Geneviève, Viret, Frédéric, Gonçalvès, Anthony, Turrini, Olivier, Delpero, Jean‐Robert et al. · 2011 · Genes, Chromosomes and Cancer
  73. Estimation of rearrangement phylogeny for cancer genomes
    Chris Greenman, Erin Pleasance, Scott Newman, Fengtang Yang, Beiyuan Fu, Serena Nik‐Zainal, David Jones, King Wai Lau, Nigel Carter, Paul A. Edwards et al. · 2011 · Genome Research
  74. Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases
    Han‐Sin Jeong, Dennis Jones, Shan Liao, Daniel A. Wattson, Cheryl H. Cui, Dan Gabriel Duda, Christopher G. Willett, Rakesh K. Jain, Timothy P. Padera · 2015 · JNCI Journal of the National Cancer Institute
  75. Computational analysis of cancer genome sequencing data
    Isidro Cortés‐Ciriano, D. Gulhan, Jake June-Koo Lee, Giorgio E. M. Melloni, Peter J. Park · 2021 · Nature Reviews Genetics
  76. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers
    Melissa Q. McCreery, Kyle D. Halliwill, Douglas Chin, Reyno Delrosario, Gillian L. Hirst, Peter T. Vuong, Kuang‐Yu Jen, James Hewinson, David J. Adams, Allan Balmain · 2015 · Nature Medicine
  77. The complex landscape of pancreatic cancer metabolism
    C. M. Sousa, Alec C. Kimmelman · 2014 · Carcinogenesis
  78. The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Nardin Samuel, Thomas J. Hudson · 2011 · Nature Reviews Gastroenterology & Hepatology
  79. Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival
    Richard Andrew Burkhart, Peng Yu, Zoë A. Norris, Renée M. Tholey, Vanessa A. Talbott, Qin Liang, Yongxing Ai, Kathy Miller, Shruti Lal, Joseph A. Cozzitorto et al. · 2013 · Molecular Cancer Research
  80. Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
    Rodrigo Dienstmann, Jordi Ahnert Rodon, Jordi Barretina, Josep M. Tabernero · 2013 · Journal of Clinical Oncology
  81. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia
    Vikki Rand, Helen Parker, Lisa Jane Russell, Claire J. Schwab, Hannah Ensor, Julie Anne Elizabeth Irving, Lisa Jones, Dino Mašić, Lynne Minto, Heather Morrison et al. · 2011 · Blood
  82. Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers
    Sun Young Lee, Farhan Ul Haq, Deokhoon Kim, Cui Jun, Hui-Jong Jo, Sung‐Min Ahn, Won‐Suk Lee · 2014 · PLoS ONE
  83. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
    Bhuvanesh Dave, Sergio M. Granados-Principal, Rui Zhu, Stephen Charles Benz, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Ke‐Da Yu, Zhimin Shao, Xiaoxian Li, Michael Z. Gilcrease et al. · 2014 · Proceedings of the National Academy of Sciences
  84. Single cell analysis of cancer genomes
    Peter Van Loo, Thierry Voet · 2014 · Current Opinion in Genetics & Development
  85. Inferring parsimonious migration histories for metastatic cancers
    Mohammed El-Kebir, Gryte Satas, Benjamin J. Raphael · 2018 · Nature Genetics
  86. Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact
    Lei Li, Yuhong Wei, Christine To, Chang‐Qi Zhu, Jiefei Tong, Nhu‐An Pham, Paul P. Taylor, Vladimir Ignatchenko, Alexandr Ignatchenko, Wen Zhang et al. · 2014 · Nature Communications
  87. Heterogeneity and cancer.
    Kimberly H. Allison, George W. Sledge · 2014 · PubMed
  88. Advancing a clinically relevant perspective of the clonal nature of cancer
    Christian Felipe Ruiz, Elizabeth Lenkiewicz, Lisa Evers, Tara Holley, Alex Robeson, Jeffrey Kiefer, Michael J. Demeure, Michael Anthony Hollingsworth, Michael Shen, Donna E. Prunkard et al. · 2011 · Proceedings of the National Academy of Sciences
  89. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
    Elisa Giovannetti, Carolien L. van der Borden, Adam Enver Frampton, Asif Ali, Omidreza Firuzi, Godefridus J. Peters · 2017 · Seminars in Cancer Biology
  90. Intratumoral heterogeneity and drug resistance in cancer
    Yue-Chun Fu, Shao-Bo Liang, Min Luo, Xue‐Ping Wang · 2025 · Cancer Cell International
  91. LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
    Prue A. Cowin, Joshy George, Sián Fereday, Elizabeth A. Loehrer, Peter Van Loo, Carleen M. Cullinane, Dariush Etemadmoghadam, Sarah Ftouni, Laura Galletta, Michael S. Anglesio et al. · 2012 · Cancer Research
  92. Cancer in Light of Experimental Evolution
    Kathleen Sprouffske, Lauren M.F. Merlo, Philip J. Gerrish, Carlo C. Maley, Paul Sniegowski · 2012 · Current Biology
  93. Radiomics in Oncological PET/CT: Clinical Applications
    Jeong Won Lee, Sang Mi Lee · 2017 · Nuclear Medicine and Molecular Imaging
  94. Characterizing complex structural variation in germline and somatic genomes
    Aaron R. Quinlan, Ira M. Hall · 2011 · Trends in Genetics
  95. Processed pseudogenes acquired somatically during cancer development
    Susanna L. Cooke, Adam Shlien, John Marshall, Christodoulos Pipinikas, Sancha Martin, José M. C. Tubío, Yilong Li, Andrew H. Menzies, Laura J. Mudie, Manasa Ramakrishna et al. · 2014 · Nature Communications
  96. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP
    Nan Li, Guohua Yang, Liyun Luo, Ling Li, Xiaorong Wang, Lejuan Shi, Junsong Lan, Xiaoting Jia, Qiong Zhang, Ze Long et al. · 2019 · Clinical Cancer Research
  97. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis
    Leila Sabour, Maryam Sabour Takanlou, ‪Saeid Ghorbian · 2016 · Pathology & Oncology Research
  98. Cancer genome-sequencing study design
    Jill C. Mwenifumbo, Marco A. Marra · 2013 · Nature Reviews Genetics
  99. Direct reprogramming by oncogenic Ras and Myc
    Irene Ischenko, Jizu Zhi, Ute Martha Moll, Alice Nemajerová, Oleksi Petrenko · 2013 · Proceedings of the National Academy of Sciences
  100. Tumor Heterogeneity in Pancreatic Adenocarcinoma
    Jerome F. Cros, Jérôme Raffenne, Anne Couvelard, Nicolas Poté · 2017 · Pathobiology